STAT+: Medicare’s miss on Alzheimer’s drug spending

Far fewer seniors than expected are taking costly Alzheimer's drugs.
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

Far fewer seniors than expected are taking costly Alzheimer's drugs.
Source
Stat News
Opens original article in a new tab

Last year, the FDA had warned that natural opioids in kratom were being turned into harmful products. Now President Trump says approval should be considered.

(MedPage Today) -- Human papillomavirus (HPV) vaccination rates varied substantially across and within U.S. regions, according to estimates in a retrospective, cross-sectional analysis, suggesting targeted interventions should focus on the needs...

A new FDA policy will let some flavored vapes stay on the market without authorization.

(MedPage Today) -- A less invasive treatment option for gastroesophageal reflux disease (GERD) resulted in similar improvements in symptoms and quality of life with less dysphagia compared with gold-standard surgical therapy, according to a prospective...